Article

Exercise Levels May Affect Adolescents with Fibromyalgia

Being physically active can help adolescent fibromyalgia patients report lower levels of pain and disability according to the results of a study published in The Journal of Pain.

Being physically active can help adolescent fibromyalgia patients report lower levels of pain and disability, according to the results of a study published in The Journal of Pain.

The study was led by researchers at the Cincinnati Children’s Hospital. The team used actigraphy-based physical activity monitoring to measure the relationship of pain, perceived functional impairment and depressive symptoms in adolescents with juvenile primary fibromyalgia syndrome (JPFS).

The study included 104 adolescents, ages 11-18. The subjects were fitted with hip-mounted actigraphs for one week. The device measures the amount and intensity of human physical activity.

The results demonstrated that adolescents with JPFS did not engage in physical activities and aerobic exercise at levels recommended by their physicians. Only 23% of the subjects participated in 30 minutes of daily moderate-to-vigorous physical exercise. Only one adolescent engaged in 60 minutes of exercise daily.

The study also revealed that higher pain intensity ratings were not significantly associated with lower levels of activity in the group. The authors noted that fatigue and impaired sleep may have affected the activity levels. Higher pain levels in the least active group may have been related to their decreased activity as well, the researchers said.

The inactive group had higher levels of depressive symptoms and functional disability, according to the parent reports. The small number of JPFS patients that maintained very high levels of physical exercise reported pain levels that were lower than the inactive group, which may have correlated with exercising. The parents of these adolescents also reported that they had lower depressive symptoms and disability.

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
© 2024 MJH Life Sciences

All rights reserved.